DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 10 of 15 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
指定難病告示番号
1
BRD4
-
D11131
D11131
Apabetalone
1件:
86
86
2
BCL2
43件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
Platinum drug resistance
,
NF-kappa B signaling pathway
,
HIF-1 signaling pathway
,
Sphingolipid signaling pathway
,
p53 signaling pathway
,
Autophagy - animal
,
Protein processing in endoplasmic reticulum
,
PI3K-Akt signaling pathway
,
Apoptosis
,
Apoptosis - multiple species
,
Necroptosis
,
Adrenergic signaling in cardiomyocytes
,
Hedgehog signaling pathway
,
Focal adhesion
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Neurotrophin signaling pathway
,
Cholinergic synapse
,
Estrogen signaling pathway
,
Parathyroid hormone synthesis, secretion and action
,
AGE-RAGE signaling pathway in diabetic complications
,
Amyotrophic lateral sclerosis
,
Pathways of neurodegeneration - multiple diseases
,
Shigellosis
,
Salmonella infection
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Measles
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Human immunodeficiency virus 1 infection
,
Pathways in cancer
,
MicroRNAs in cancer
,
Chemical carcinogenesis - receptor activation
,
Colorectal cancer
,
Prostate cancer
,
Small cell lung cancer
,
Gastric cancer
,
Lipid and atherosclerosis
,
Fluid shear stress and atherosclerosis
43件:
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
Platinum drug resistance
,
NF-k
...
D10679
D10679
Venetoclax
1件:
28
28
3
BRD2
-
D11131
D11131
Apabetalone
1件:
86
86
4
BRAF
44件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB signaling pathway
,
Rap1 signaling pathway
,
cAMP signaling pathway
,
Chemokine signaling pathway
,
FoxO signaling pathway
,
mTOR signaling pathway
,
Vascular smooth muscle contraction
,
Focal adhesion
,
Natural killer cell mediated cytotoxicity
,
Long-term potentiation
,
Neurotrophin signaling pathway
,
Serotonergic synapse
,
Long-term depression
,
Regulation of actin cytoskeleton
,
Insulin signaling pathway
,
Progesterone-mediated oocyte maturation
,
Parathyroid hormone synthesis, secretion and action
,
Cushing syndrome
,
Alzheimer disease
,
Pathways of neurodegeneration - multiple diseases
,
Alcoholism
,
Hepatitis C
,
Hepatitis B
,
Pathways in cancer
,
Proteoglycans in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
Colorectal cancer
,
Renal cell carcinoma
,
Pancreatic cancer
,
Endometrial cancer
,
Glioma
,
Prostate cancer
,
Thyroid cancer
,
Melanoma
,
Bladder cancer
,
Chronic myeloid leukemia
,
Acute myeloid leukemia
,
Non-small cell lung cancer
,
Breast cancer
,
Hepatocellular carcinoma
,
Gastric cancer
44件:
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB s
...
D08524
D08524
Sorafenib
2件:
34
34
,
86
5
BRAF
44件:
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB signaling pathway
,
Rap1 signaling pathway
,
cAMP signaling pathway
,
Chemokine signaling pathway
,
FoxO signaling pathway
,
mTOR signaling pathway
,
Vascular smooth muscle contraction
,
Focal adhesion
,
Natural killer cell mediated cytotoxicity
,
Long-term potentiation
,
Neurotrophin signaling pathway
,
Serotonergic synapse
,
Long-term depression
,
Regulation of actin cytoskeleton
,
Insulin signaling pathway
,
Progesterone-mediated oocyte maturation
,
Parathyroid hormone synthesis, secretion and action
,
Cushing syndrome
,
Alzheimer disease
,
Pathways of neurodegeneration - multiple diseases
,
Alcoholism
,
Hepatitis C
,
Hepatitis B
,
Pathways in cancer
,
Proteoglycans in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
Colorectal cancer
,
Renal cell carcinoma
,
Pancreatic cancer
,
Endometrial cancer
,
Glioma
,
Prostate cancer
,
Thyroid cancer
,
Melanoma
,
Bladder cancer
,
Chronic myeloid leukemia
,
Acute myeloid leukemia
,
Non-small cell lung cancer
,
Breast cancer
,
Hepatocellular carcinoma
,
Gastric cancer
44件:
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB s
...
D10064
D10064
Dabrafenib
1件:
34
34
6
BRDT
-
D11131
D11131
Apabetalone
1件:
86
86
7
BTK
7件:
NF-kappa B signaling pathway
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor signaling pathway
,
Fc epsilon RI signaling pathway
,
Epstein-Barr virus infection
,
Primary immunodeficiency
7件:
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor s
...
D10223
D10223
Ibrutinib
3件:
28
28
,
60
,
61
8
BTK
7件:
NF-kappa B signaling pathway
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor signaling pathway
,
Fc epsilon RI signaling pathway
,
Epstein-Barr virus infection
,
Primary immunodeficiency
7件:
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor s
...
D10893
D10893
Acalabrutinib
2件:
46
46
,
61
9
BTK
7件:
NF-kappa B signaling pathway
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor signaling pathway
,
Fc epsilon RI signaling pathway
,
Epstein-Barr virus infection
,
Primary immunodeficiency
7件:
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor s
...
D11422
D11422
Zanubrutinib
5件:
13
13
,
63
,
222
,
300
,
331
10
BTK
7件:
NF-kappa B signaling pathway
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor signaling pathway
,
Fc epsilon RI signaling pathway
,
Epstein-Barr virus infection
,
Primary immunodeficiency
7件:
NF-kappa B signaling pathway
,
Osteoclast differentiation
,
Platelet activation
,
B cell receptor s
...
D11457
D11457
Fenebrutinib
1件:
13
13